*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

I see treblewide is back whining again (like a silly child), keep up the research banjomick, it's all interesting to holders and people who are concerned about the future re. Prostate Cancer.

oh oh...back up has arrived.

Morning Minder,

Advising wait-and-see approach on low-grade prostate cancer

By Stephanie Desmon
The Baltimore Sun
Posted March 10, 2009

"Dr. Ian Thompson, chairman of urology at the University of Texas Health Sciences Center, agrees. "Men look at prostate cancer and they think cancer 'the Big C.' And they think, like pancreatic cancer and lung cancer, 'I must treat it,' " Thompson said. "But it's a different disease ... than many other cancers."

In the past two decades, the number of American men diagnosed with prostate cancer has skyrocketed there were an estimated 186,000 new cases last year as a blood test that looks for a protein called prostate-specific antigen (PSA) has become more routine."

"Thanks to PSA, many of the cancers being found are much smaller and less dangerous than those that had been discovered through physical exams. So the question has become: What should be done about them?

"That really is the big conundrum in prostate cancer, whom to treat," said Dr. Howard Parnes, chief of the prostate and urological research group at the National Cancer Institute in Bethesda. "Many more men die with prostate cancer than from prostate cancer."

In determining whether a patient is a candidate for active surveillance, Carter looks at PSA levels, whether a tumor is palpable during a physical exam and a score based on the microscopic appearance of cancer cells in prostate tissue, which gives an idea of a cancer's aggressiveness.

Carter cautions that he is "incredibly conservative" about whom he chooses for surveillance. He rarely includes men in their 50s because if he and his staff are wrong, the chances of harm are greater. Older men are more likely to have other diseases that are likely to claim them before the cancer does."

http://wenatcheeworld.com/article/20090310/HEALTH/703109996?Advising-wait-and-see-approach-on-low-grade-prostate-cancer

I had a 37year old friend who was diagnosed with Ca prostate, just after he had achieved a consultant's post. He died 2 years later leaving a wife and young family.

Possibly, with routine PSA testing and following up with biopsies, he may have had earlier successful treatment and been alive today.

I foresee, that in the near future PSAs will be routine from about 25years of age and repeatedly with routine 2-3 yearly follow ups carried out under the NHS.

Sorry to hear about your friend,Fred.

I think the most important part in the fight against PC is the first test to act as a datum and getting this done early.Depending on the results and age of the man then yes a re-test after 2-3 years would be about right,imo.

Getting the first test done early obviously makes for a better chance in picking up possible PC especially in those classed as a low risk due to their age.

I'll post this here as well as over the road,just for treble:

Gwent cancer patient takes screening plea to Assembly
4:20pm Thursday 12th March 2009


A GWENT prostate cancer patient has taken his campaign for a screening programme to help detect the disease to the Assembly.

Reg Williams, 59, who lives near Chepstow, set up the Prostate Screening Trust three years ago in the aftermath of his own diagnosis, to lobby for a PSA (prostate specific antigen) test to be made available for men.

Mr Williams wants the group to be the first in Wales to offer a PSA monitoring service.

He spoke to AMs at the Senedd about a new mobile PSA machine, which uses an analysis of a finger-prick blood sample to give a PSA result in 20 minutes.

NICE, the National Institute for Clinical Excellence, is currently studying the cost effectiveness and efficiency of PSA screening, and a programme will not be introduced in Wales or anywhere else while this continues.

Should NICE deem it unviable this situation will continue, but Mr Williams believes a screening programme has a vital role to play.

"Prostate cancer cases are overtaking breast cancer in Wales, according to 2007 figures. Something needs to be done," said Mr Williams.

"There was a surge in cases from 2006, and I'm convinced that was partly down to the high profile prostate cancer received through the campaign to get brachytherapy available again as a treatment for patients in Wales.

"People are beginning to take this issue (of screening) more seriously and at the Senedd.

I showed AMs and others who were interested the new machine.

"There is also a need of course, to have NICE speed up its procedures for studying new treatments and drugs. And men should realise the importance of getting checked for prostate cancer.

The PSA test is not considered a reliable screening tool for detecting prostate cancer and its more and less aggressive forms, but Mr Williams believes men should have the option.

"A lot of men I have spoken to have been picked up for prostate cancer after having a PSA test through their private medical care," he said.

He hopes, through the trust, to be able to offer men aged over 50 a PSA test using the new technology.

Further information on prostate cancer, and the trust's aims can be found at www.prostatescreeningtrust.co.uk

http://www.southwalesargus.co.uk/news/4198537.Gwent_cancer_patient_takes_screening_plea_to_Assembly/

It's well worth watching the video on RHS.

Former Radio DJ Speaks Out About Prostate Cancer
Posted Thursday, March 12,

A former Huntington radio personality is telling his story, to help others struggling with prostate cancer.
Story by Gina Long

HUNTINGTON -- You might not recognize his face, but many people in the Tri-State will recognize his voice.

"I've led a rather public life, most of my life, and most everyone knows as much about me as possible," said former Huntington radio personality Jack O'Shea.

But what most people don't know about O'Shea, is that he was diagnosed with prostate cancer last spring, after a routine blood test.

http://www.statejournal.com/story.cfm?func=viewstory&storyid=54271

Nurse raises awareness of prostate cancer

Published Date: 11 March 2009
A practice nurse from Leyland is using her brother's experience to help save the lives of her patients.

Louise Howe works for Moss Side Medical Centre and is raising awareness of the dangers of prostate cancer, which kills one man in Britain every hour.

Her own brother Phil has undergone treatment for the disease and now she wants other men not to be embarrassed about seeing their GP.

She said: "Men really, really don't like coming to the doctors, particularly for anything that affects them below the waist!"

It was four years ago when Louise was part-way through her nurse training that she found out her brother had prostate cancer.

"It all started when my sister-in-law booked a 'well woman' check," she explained. "She'd just lost a second close friend to ovarian cancer and decided to get her own health checked out.

"When my brother, Phil, said it was a good idea, she replied 'you're coming too!' She'd made an appointment for him to have a 'well man check' at the same time."

The results of Phil's prostate test showed a high level of the PSA (prostate specific androgen) hormone.

He then went for a biopsy which indicated advanced prostate cancer.

"His options were limited," said Louise. "The tumour had grown outside of his prostate. It wasn't operable, but it was treatable."

The Leyland nurse recalls how the diagnosis left the family reeling. "My brother was just 53 which is an early age to develop the disease. Also, he showed absolutely no symptoms of anything being wrong. This came completely out of the blue."

Phil, now 57 and living in Lancashire, underwent radiotherapy and is having monthly injections of drugs to control the cancer.

Prostate UK is the leading charity in the fight against all prostate diseases. More information about the condition can be found at www.prostateuk.org

http://www.leyland-guardian.co.uk/leyland/Nurse-raises-awareness-of-prostate.5061832.jp

Stampede for prostate check

by LISA BUCKLEY

UNPRECEDENTED demand for a health awareness event has forced hospital bosses to appeal to those without an appointment to stay away.

Organisers of a Prostate Awareness event at the George Eliot Hospital tomorrow have been inundated with requests.

All 170 places for the free prostate health check were snapped-up within two days of the event being promoted in the Nuneaton News.

Charitable funds co-ordinator Jean Whittaker, who is helping to organise the event, said that they are truly sorry that they can't see everyone but it is simply impossible.

All the staff who are working tomorrow at the event staged in the George Eliot Training and Education Centre (GETEC) are doing so on a voluntary basis, with the session paid for thanks to fundraising by a dedicated doctor.

"The response has been unbelievable - my phone has literally not stopped ringing for the past three weeks," said Mrs Whittaker, who was awarded an MBE last year for her fundraising work for the George Eliot Hospital.

"I am just so sorry that we are not going to be able to see everyone. Everyone who is working at the event on Saturday is volunteering their own time and costs incurred on the day have been paid for with money raised by Dr Handslip from a sponsored walk.

"I'd like to personally thank everyone who has given up their time to make this event happen.

"While we can't see everyone I would urge anyone who thinks they may have symptoms or has a family history of prostate problems to approach their GP who will be able to provide a check-up."

http://www.nuneaton-news.co.uk/nuneatonnews/DisplayArticle.asp?ID=399484

Think a part repeat of a post back in January is worth a re-post:

"What also caught my eye (ouch!) within the results was the geographical analysis of MDW's revenue compared to last years.

UK up 58%

USA up 19%

Continental Europe up 50%

Rest of the World up 52%

Total up 39%

Year ended 31 October 2008 000----------- Year ended 31 October 2007 000
United Kingdom 1,867 ------------------------777
United States of America 3,911--------------- 3,162
Continental Europe 2,203--------------------- 1,092
Rest of the world 1,346----------------------- 653

Total 9,327-----------------------------------5,684

(please forgive format)

the above figures show that the USA is obviously the biggest single revenue generator but has only gained 19% compared to last year,so why is that?

From July's Interims:

US Office

"The Company has made some operational improvements in the US division. A clinical group has been established including a VP of Clinical Services along with a Clinical Services Manager. This team will bring a high level of expertise and many years of experience in Urodynamics to the Group and will begin offering Urodynamic clinics to customers, provide clinical assistance to customers and upgrade the delivery service of capital equipment.

The US Division is in the process of reorganising the sales team. This change was brought on by the retirement of the existing VP of Sales Dan Parker. The company would like to thank Mr. Parker for his contributions to the business. The new VP of Sales and Marketing for the US division is Mr. Rick Hogan. Rick is a graduate of St. Joseph's University and attended graduate courses at Villanova University. He is a proven leader with 20 years domestic and international experience building businesses in the life science and medical device industries. Rick has marketed medical technology throughout the entire continuum of care. Recent leadership assignments include: Vice President Sales and Marketing & Acting CEO, Diagnostic Test Group; General Manager, Orex Imaging; General Manager, Kinetic Concepts and Eastern Zone Manager, Becton Dickinson (BD), Point of Care Division.

The appointment of Rick Hogan will be of great benefit to the company in growing the business in the biomedical diagnostics area of products where the company sees a great opportunity for expansion.

The new Portable Urodynamic equipment has been distributed to the sales team for demonstration and sales purposes. This equipment will allow the team to carry their demonstration equipment rather than shipping the larger units. This will significantly increase the number of demonstrations the team will be able to perform and significantly reduce the cost of conducting demonstrations. The company feels that there is significant demand for a smaller portable unit and this product will fill this gap in our product lines."



My view is that the USA division although still doing very well with a 19% increase were not up to full speed,as it were and this has been seen in the H2 for 2008 which covers up to 31st October 2008 (obv.)

The fact that all other regions have increased revenues by 50% or more is very good news and bodes well for 2009 H1 for all and the USA in particular! imo.

In my view what we will see through 2009 is the USA playing catch-up as far as sales are concerned and this is why MDW have emphasised the USA events that they will be exhibiting at during this year!

On the 16th of March 2009, the eyes of the UK's healthcare sector will be on Central London, for the unveiling of the Medilink UK Awards 2009.

http://www.medilinkuk.com/events/display.php?id=413&crumb=National%20Events

Previous news:


The Cream of the UK Healthcare Technology Sector is Announced

The Medilink UK Awards, sponsored by Xiros Plc, celebrate cutting edge technologies, outstanding business achievements and international success and collaboration and have been designed to showcase the cream of the healthcare industry.

Held at Haberdashers Hall, London on Monday 16th March, the Medilink UK Awards 2009 is being run in association with UK Trade & Investment (UKT&I), Health Technologies KTN, BERR (Department for Business Enterprise and Regulatory Reform, the NHS National Innovation Centre (NIC) and NIHR (National Institute for Health Research).

The nominees for each of the five awards Export Achievement, Innovation, Growth in Sector, Partnership with the NHS and Start Up - are made up of regional winners from the Medilink Awards and are selected by a panel of sector specialists from the 12 UK regions.

All the winners will be announced on the day and there will also be speeches from a wide range of specialist from across the healthcare industry.

The nominees for this years awards include:

Export Achievement Award (sponsored by UKT&I) - IDS Ltd, Mediwatch UK Ltd and Inditherm Plc


http://www.medilinkwm.co.uk/news/display.php?id=455

RNS Number : 8668O
Mediwatch PLC
16 March 2009



Five year global distribution agreement secured with
Inverness Medical Innovations


Mediwatch plc ("Mediwatch" or "the Company", AIM: MDW), the innovative
urological diagnostic company, has signed a five-year agreement for the
worldwide distribution of PSAwatch, its flagship point-of-care total
PSA measuring system for prostate cancer, with Inverness Medical Innovations,
Inc. ("Inverness", NYSE: IMA) a leading provider of near-patient diagnostics,
monitoring and health management solutions.

This is a very important and substantial distribution agreement for Mediwatch as
Inverness has an extensive global sales-force which will complement Mediwatch's
own worldwide distribution network and provide the Company with considerably
more market reach. Inverness is recognised as a market leader with significant
expertise in marketing point-of-care tests, which they already manufacture for
other pathological conditions.

Prostate cancer is the second most common cause of cancer deaths with 670,000
men worldwide diagnosed with it annually. Approximately 10,000 men die every
year in the UK from prostate cancer with over 34,000 diagnosed with the disease
(Source: Cancer Research UK). There are 60 million PSA tests globally with
PSAwatch the first quantitative, point-of-care PSA test in this GBP300 million
market. It uses the Mediwatch Bioscan reader and therefore does not require
laboratories.

Philip Stimpson, Mediwatch Chief Executive commented'


"We are confident that this strategically important distribution agreement will
deliver a significant revenue stream. The market for point of care diagnostics
is growing rapidly as a result of a combination of; the population aging, growth
of local clinics, home testing and the need for faster, cheaper, more portable
and easier to use medical equipment.

"This is a significant development for Mediwatch as it means we can both
actively promote worldwide the early diagnosis of prostate cancer, with portable
rapid-testing equipment. This is particularly poignant and gratifying for us,
being a British company, as this is Prostate Cancer Awareness Month in the UK."

Some information on Inverness Medical Innovations:


Inverness Medical Innovations, Inc. (NYSE: IMA) is at the forefront of the convergence between medical diagnostic testing and health management. IMA is a major global developer, manufacturer and marketer of advanced, pioneering professional and consumer medical diagnostic products, as well as a leader in specialized health management services including wellness, disease management, oncology and women and children's health.

http://www.invernessmedical.com/

Along with MDW's own global distribution network the Inverness deal includes the following,which is nice! :-)

http://www.invernessmedical.com/inverness-worldwide/latin-america--africa.aspx

http://www.invernessmedical.com/inverness-worldwide/north-america.aspx

http://www.invernessmedical.com/inverness-worldwide/asia-pacific.aspx

http://www.invernessmedical.com/inverness-worldwide/europe--middle-east.aspx

So,Inverness have signed a 5 year deal for the distribution of PSAwatch before it has gained FDA approvals!

Therefore,Inverness must be confident that the FDA will approve PSAwatch as the US has the largest market for PSA testing at the present time.

Does this mean FDA approvals are arriving sooner rather than later? Or/and do Inverness see Africa for example,as an even bigger market?


Five year global distribution agreement secured with Inverness Medical Innovations

Mediwatch picks up global distribution deal with Inverness Medical Innovations


16 March 2009

Urological diagnostics group Mediwatch has signed a five-year agreement for the worldwide distribution of PSAwatch, its flagship point-of-care total PSA measuring system for prostate cancer, with US health company Inverness Medical Innovations, Inc.

Mediwatch described the deal as a very important and substantial distribution agreement because Inverness has an extensive global sales force which will complement Mediwatch's own worldwide distribution network and provide the company with considerably more market reach.

Philip Stimpson, Mediwatchs chief executive, commented: We are confident that this strategically important distribution agreement will deliver a significant revenue stream. The market for point of care diagnostics is growing rapidly as a result of a combination of; the population aging, growth of local clinics, home testing and the need for faster, cheaper, more portable and easier to use medical equipment.

This is a significant development for Mediwatch as it means we can both actively promote worldwide the early diagnosis of prostate cancer, with portable rapid-testing equipment.

http://www.smallcapnews.co.uk/article/Mediwatch_picks_up_global_distribution_deal_with_Inverness_Medical_Innovations/6942.aspx

still think it will test the lows again...i will be buying at about 5p if it gets there......risk/return at that level is good for me...at 8p it is not

LOL,
The chance to buy at sub 5p was there for all treblewide, you missed it though so just get on with it and buy some now (you know you want to :o)

The Cleveland Clinic event relating to 'Female Pelvic floor Disorders' finishes today and the next event MDW are exhibiting at is:


24th Annual EAU Congress Stockholm 17th - 21st March 2009

Scientific Programme

Oh,he's back again!

A repeat post but as the Stockholm EAU congress starts tomorrow......

"Not sure if Mark Emberton will be speaking at the Stockholm EAU congress as a non-executive Director of MDW or as an expert in the field of prostate cancer,probably the latter but all good publicity!

Prostate Cancer

Per-Anders Abrahamsson, Malm(SW), Frans M.J. Debruyne, Arnhem (NL), Mark Emberton, London (GB) and Manfred Wirth, Dresden (DE).

EAU TV is part of the EAU's initiatives to actively use contemporary electronic media such as podcast, webinars and TV news. For example, all congress sessions will be webcasted."

http://www.medicalnewstoday.com/articles/140822.php